<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Oncologix Tech Inc — News on 6ix</title>
<link>https://6ix.com/company/oncologix-tech-inc</link>
<description>Latest news and press releases for Oncologix Tech Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 02 May 2022 18:46:09 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/oncologix-tech-inc" rel="self" type="application/rss+xml" />
<item>
<title>DNAGO and Oncologix Tech, Inc. Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Providing clinical genetic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases at affordable price</title>
<link>https://6ix.com/company/oncologix-tech-inc/news/dnago-and-oncologix-tech-inc-announce-agreement-for-business-combination-to-create-publicly-listed-company-focused-on-providing-clinical-genetic-testing-on-all-20000-genes-encompassing-7000-rare-genetic-diseases-at-affordable-price</link>
<guid isPermaLink="true">https://6ix.com/company/oncologix-tech-inc/news/dnago-and-oncologix-tech-inc-announce-agreement-for-business-combination-to-create-publicly-listed-company-focused-on-providing-clinical-genetic-testing-on-all-20000-genes-encompassing-7000-rare-genetic-diseases-at-affordable-price</guid>
<pubDate>Mon, 02 May 2022 18:46:09 GMT</pubDate>
<description>DNAGO and Oncologix Tech, Inc. Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Providing clinical genetic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases at affordable price.</description>
</item>
<item>
<title>Alpharidge Capital announces “Custodianship Updates”: live Shareholder Conference Call slated for Monday, October 18th, 2021 on Zoom</title>
<link>https://6ix.com/company/oncologix-tech-inc/news/alpharidge-capital-announces-custodianship-updates-live-shareholder-conference-call-slated-for-monday-october-18th-2021-on-zoom-3</link>
<guid isPermaLink="true">https://6ix.com/company/oncologix-tech-inc/news/alpharidge-capital-announces-custodianship-updates-live-shareholder-conference-call-slated-for-monday-october-18th-2021-on-zoom-3</guid>
<pubDate>Thu, 14 Oct 2021 23:07:15 GMT</pubDate>
<description>Alpharidge Capital announces “Custodianship Updates”: live Shareholder Conference Call slated for Monday, October 18th, 2021 on Zoom.</description>
</item>
<item>
<title>ONCOLOGIX TECH, INC. ANNOUNCES RELEASE OF UNAUDITED FINANCIAL RESULTS</title>
<link>https://6ix.com/company/oncologix-tech-inc/news/oncologix-tech-inc-announces-release-of-unaudited-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/oncologix-tech-inc/news/oncologix-tech-inc-announces-release-of-unaudited-financial-results</guid>
<pubDate>Fri, 19 Jan 2018 15:30:35 GMT</pubDate>
<description>ONCOLOGIX TECH, INC. ANNOUNCES RELEASE OF UNAUDITED FINANCIAL RESULTS.</description>
</item>
<item>
<title>ONCOLOGIX TECH, INC. ANNOUNCES INCREASE IN TOTAL NUMBER OF SHARES OF AUTHORIZED COMMON STOCK</title>
<link>https://6ix.com/company/oncologix-tech-inc/news/oncologix-tech-inc-announces-increase-in-total-number-of-shares-of-authorized-common-stock</link>
<guid isPermaLink="true">https://6ix.com/company/oncologix-tech-inc/news/oncologix-tech-inc-announces-increase-in-total-number-of-shares-of-authorized-common-stock</guid>
<pubDate>Fri, 15 Sep 2017 21:00:00 GMT</pubDate>
<description>ONCOLOGIX TECH, INC. ANNOUNCES INCREASE IN TOTAL NUMBER OF SHARES OF AUTHORIZED COMMON STOCK.</description>
</item>
<item>
<title>Oncologix Announces Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations</title>
<link>https://6ix.com/company/oncologix-tech-inc/news/oncologix-announces-voluntary-filing-of-form-15-to-suspend-sec-reporting-obligations</link>
<guid isPermaLink="true">https://6ix.com/company/oncologix-tech-inc/news/oncologix-announces-voluntary-filing-of-form-15-to-suspend-sec-reporting-obligations</guid>
<pubDate>Wed, 23 Aug 2017 20:29:43 GMT</pubDate>
<description>Oncologix Announces Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations.</description>
</item>
</channel>
</rss>